WuXi Biologics adds 4,000L bioreactors at fully single-use site

The CMO says adding the single-use offering from ABEC will make the newly opened biomanufacturing site in China comparable to stainless steel for commercial mAb production.

HTTPS://WWW.BIOPHARMA-REPORTER.COM/ARTICLE/2018/03/21/WUXI-BIOLOGICS-ADDS-4-000L-BIOREACTORS-AT-FULLY-SINGLE-USE-SITE